denovoMATRIX is a German biotechnology startup founded in 2018, with the slogan "Enabling biology in vitro." The company's primary focus is on offering a combinatorial screening matrix product for life science researchers. This product enables researchers to identify the best tailor-made biomaterials for their specific cell types, individual research questions, and potential future medical applications.
The startup successfully secured a Seed Round investment on 13 December 2018, with participation from High-Tech Gründerfonds and TGFS - Technologiegründerfonds Sachsen.
With its innovative approach to addressing the needs of life science researchers, denovoMATRIX is poised to make significant strides in the biotechnology sector. The company's ability to offer customized solutions to a burgeoning market showcases its potential for sustained growth and impact within the industry.